Good
Mostly Aligned
Patient Risk:
Low
Summary
Most claims about METROGEL being metronidazole 1% topical gel and indicated for inflammatory rosacea lesions are consistent with the provided label excerpts. However, several claims are either overly general (e.g., “generally topical metronidazole,” “other brand names”) or not supported/assessed by the provided label text (e.g., acne/rosacea-type skin conditions).
Category Scores
Accurate Statements
Metrogel is a brand name.
Provided label text identifies the drug as METROGEL® (brand) with active ingredient metronidazole.
The corresponding generic name (active ingredient) for Metrogel is metronidazole.
Drug/Active ingredient(s) section: Active ingredient: Metronidazole (topical gel); and label text refers to metronidazole in sections (e.g., indications, warnings, adverse reactions).
Different manufacturers may sell topical metronidazole gel under other brand names.
Not directly supported or refuted by the provided label excerpts (there is no statement in the excerpts about other manufacturers/brand naming).
Unsupported Statements
Metrogel products are generally topical metronidazole.
The provided label confirms METROGEL® is topical metronidazole 1% gel, but does not support the generalization that 'Metrogel products' are generally topical metronidazole across all products.
Metrogel is used for acne/rosacea-type skin conditions.
The provided label excerpt states METROGEL® is indicated for topical treatment of inflammatory lesions of rosacea; it does not mention acne.
The generic name stays metronidazole for topical metronidazole gel sold under other brand names.
The provided label excerpts do not address other brands or whether their generic naming remains metronidazole.
Contradictions
Low
AI Statement
Metrogel is used for acne/rosacea-type skin conditions.
Label Reference
Indications and Usage: “METROGEL® is indicated for the topical treatment of inflammatory lesions of rosacea.” (no acne indication provided in the excerpt)
Important Omissions
Recommended dosing instructions (e.g., 'Apply and rub in a thin film once daily') and use limitations ('Not for oral, ophthalmic or intravaginal use') are not addressed by the AI claims provided.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The only safety-relevant potential issue is the implied broader indication ('acne/rosacea-type'), which may encourage off-label use for acne; no dosage/safety instructions were claimed.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
Yes |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Indication claim includes acne, which is not supported by the provided METROGEL label excerpt (rosacea only).
Suggested Improvement
Restrict indication wording to 'inflammatory lesions of rosacea' as stated in the label excerpt, and avoid unlabelled generalizations about other brands/manufacturers.